Literature DB >> 34743279

ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Marco Tonello1, Antonio Sommariva2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34743279     DOI： 10.1245/s10434-021-11057-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  1 in total

1.  Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.

Authors:  François Quénet; Dominique Elias; Lise Roca; Diane Goéré; Laurent Ghouti; Marc Pocard; Olivier Facy; Catherine Arvieux; Gérard Lorimier; Denis Pezet; Frédéric Marchal; Valeria Loi; Pierre Meeus; Beata Juzyna; Hélène de Forges; Jacques Paineau; Olivier Glehen
Journal:  Lancet Oncol       Date:  2021-01-18       Impact factor: 41.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.